首都医科大学学报 ›› 2021, Vol. 42 ›› Issue (4): 635-641.doi: 10.3969/j.issn.1006-7795.2021.04.020

• 临床研究 • 上一篇    下一篇

中文版世界卫生组织生存质量测定量表简表用于终末期肾病的信效度验证

刘怡均1, 林向英1*, 张燕2   

  1. 1.中国农业大学烟台研究院,山东烟台 264003;
    2.山东省烟台市毓璜顶医院肾内科,山东烟台 264000
  • 收稿日期:2021-04-06 出版日期:2021-08-21 发布日期:2021-07-29
  • 基金资助:
    2021年度国家级大学生创新创训练项目(202110019090)。

Validity and reliability of the Chinese version ofWorld Health Organization Quality of Life-BREF among patients with end-stage renal disease

Liu Yijun1, Lin Xiangying1*, Zhang Yan2   

  1. 1. Yantai Institute of China Agricultural University, Yantai 264003, Shandong Province, China;
    2. Department of Nephrology, Yantai Yuhuangding Hospital,Yantai 264000, Shandong Province, China
  • Received:2021-04-06 Online:2021-08-21 Published:2021-07-29
  • Contact: * E-mail:xiangyinglin@163.com
  • Supported by:
    National Innovation and Entrepreneurship Training Program for College Students(202110019090).

摘要: 目的 验证并评价中文版世界卫生组织生存质量测定量表简表(the World Health Organization Quality of Life-BREF,WHOQOL-BREF)应用于终末期肾病患者生存质量评估时的信效度。方法 本研究通过分层比例抽样方法选取山东省烟台市某三甲医院Y的55名终末期肾病患者填写中文版WHOQOL-BREF。结果 量表内部一致性信度良好;分别采用专家评定法和相关系数法进行内容效度检验后发现量表具备较好的内容效度;不同低保、透析龄、目前个人月收入和患病前的家庭月收入的终末期肾病患者在周围环境领域得分不同(P<0.05),其判别效度尚可。结论 中文版WHOQOL-BREF适用于终末期肾病患者生存质量的评估,具有较好的信效度。

关键词: 终末期肾病, 世界卫生组织生存质量测定量表简表, 信度, 效度

Abstract: Objective To verify the reliability and validity of the Chinese version of the World Health Organization Quality of Life-BREF(WHOQOL-BREF) among patients with end-stage renal disease. Methods A stratified proportional sampling method was used to select 55 patients with end-stage renal disease in a grade a class Ⅲ-hospital Y in Yantai City, Shandong Province. Results WHOQOL-BREF had a nice internal consistency. The content validity was conducted by the expert evaluation method and the correlation coefficient method, having a good content validity. End-stage renal disease(ESRD) patients with different subsistence allowances, dialysis age, current personal monthly income and household monthly income before illness had different scores in the area of surrounding environment (P<0.05). It meant that the scale hada passable discriminated validity. Conclusion The Chinese version of WHOQOL-BREF is suitable for evaluating the quality of life of patients with end-stage renal disease and has good reliability and validity.

Key words: end-stage renal disease, the World Health Organization Quality of Life-BREF, reliability, validity

中图分类号: